A high mitotic score in breast cancer after neoadjuvant chemotherapy is predictive of outcome and associated with a distinct morphology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A high mitotic score in breast cancer after neoadjuvant chemotherapy is predictive of outcome and associated with a distinct morphology

Published:2020-03-17 Issue:5 Volume:76 Page:661-670
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Arispe Angulo Karen R¹,Jawa Zeeshan²,Visotcky Alexis³,Majidi Shadie S⁴,Chitambar Christopher R⁵,Jorns Julie M¹^ORCID

Affiliation:

1. Department of Pathology Medical College of Wisconsin Milwaukee WIUSA

2. Cancer Center of Iowa Des Moines IA USA

3. Division of Biostatistics Medical College of Wisconsin Milwaukee WI USA

4. Department of Radiology Medical College of Wisconsin Milwaukee WI USA

5. Department of Medicine Division of Hematology and Oncology Medical College of Wisconsin Milwaukee WI USA

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14049

Reference33 articles.

1. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer

2. Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

3. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

4. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

5. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP